-

Eurofins Sacramento, in Collaboration with SCIEX USA, Achieves the Lowest Detection Limits for PFAS in Drinking Water

SACRAMENTO, Calif.--(BUSINESS WIRE)--Eurofins Sacramento, part of the Eurofins (Paris:ERF) network of companies in the US, in collaboration with SCIEX USA, successfully achieved the analytical challenge of detecting the 2022 interim Health Advisory Levels (HALs) of 4ppq (parts per quadrillion) for PFOA and 20ppq for PFOS, as established by the US EPA.

The drinking water HALs for PFAS are not enforceable regulatory limits but indicate the levels below which adverse health effects are not anticipated to occur, considering lifetime exposure. The low ppq levels demand an unprecedented level of cleanliness and instrument sensitivity which ultimately necessitate newer, and more robust analytical techniques.

The results achieved provide clear evidence that ultra-trace levels of PFOA and PFOS can be detected, but with significantly increased levels of effort, cost, and environmental impact that are not sustainable for routine analysis.

With this demonstration of capabilities, Eurofins Sacramento is in the process of developing an ultra-trace method capable of supporting the analysis of PFAS in the sub-ppt range.

Methodology to Achieve the 2022 interim Health Advisory Levels

Current commercial lab limits of quantitation for PFAS are at 2ppt, requiring a 500-fold decrease for PFOA and a 100-fold for PFOS to support the US EPA HALs. Several modifications of existing procedures were employed with varying levels of success, including analysis on a SCIEX 7500, new LCMS column and traps, pre-rinsing consumables, use of water filtered through an LCMS column, and extraction in a clean room. At the conclusion of these efforts, a series of sample analyses demonstrated achievability of the 2022 interim Health Advisory Levels.

For technical specifications and data related to this development, visit the SCIEX USA technical note “Achieving low parts-per-quadrillion detection limits for PFAS analysis in drinking water”.

ENDS

About Eurofins Environment Testing – USA

The Eurofins environmental laboratories network in the US performs analysis of drinking water, groundwater, seawater, soil, air, and tissue using state-of-the-art analytical methods to assess quality and impact on health and the environment.

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With 61,000 staff across a network of 940 laboratories in 59 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

For further information:
Brooke Maharg
Brooke.Maharg@ET.EurofinsUS.com

Eurofins

BOURSE:ERF

Release Versions

Contacts

For further information:
Brooke Maharg
Brooke.Maharg@ET.EurofinsUS.com

More News From Eurofins

Eurofins MET Laboratories Opens New Safety, EMC, Wireless, and Renewable Energy Laboratory in the Boston Tech Corridor

BOSTON--(BUSINESS WIRE)--Eurofins MET Laboratories, part of the Eurofins Electrical & Electronics global network, announces the opening of its new state-of-the-art 60,000-square-foot testing laboratory in Littleton, Massachusetts – a prime location in the Boston innovation corridor. Positioned at the epicenter of New England's med-tech, wireless innovation, clean energy, and advanced electronics ecosystem, the capabilities of this laboratory further position Eurofins MET Laboratories as the...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 26th January to 30th January 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/01/2026 FR0014000MR3 5 000 70.7336 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 27/01/2026 FR0014000MR3 5 000 70.9680 XPAR EUROFINS SCIENTIFIC 529900JEHFM47...

Eurofins Delivers FY 2025 Objectives with a 24% EPS Growth, Accelerating Organic Revenue Growth, Margin Expansion, and Higher Free Cash Flow and Confirms Its 2027 Objectives

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF) pre-publishes below its preliminary unaudited consolidated financial results for the year ending 31 December 2025, as described in the first paragraphA of the Business Review section of this press release. Financial highlights in FY 2025 Basic EPS8 grew 24% to €2.31 in 2025 vs €1.87 in 2024, driven by a strong operating performance and starting to reap the benefits from Eurofins five-year investment programme in its hub and spok...
Back to Newsroom